Announcing StudyLoop.io: Invitation-Only Beta for Research Sites

We're excited to unveil StudyLoop.io, our revolutionary platform transforming clinical trial recruitment and patient engagement. For a limited time, selected research sites can try it completely free during our beta phase.

TheraNovex Launches Fully Autonomous AI Prescreening Platform: Agents Email, Call, and Schedule

Revolutionary AI agents autonomously manage the entire patient prescreening workflow—eliminating 90% of coordinator administrative burden while achieving 95% accuracy.

San Francisco, CA, February 1, 2026 — TheraNovex, a leader in clinical trial patient recruitment technology, today announced the launch of the industry’s first fully autonomous AI patient prescreening platform. This groundbreaking system operates independently without human intervention, marking a fundamental shift from "AI-assisted" tools to "AI-autonomous" recruitment operations. The TheraNovex platform introduces specialized AI agents that execute the complete patient journey: conducting complex prescreening calls, managing email correspondence, scheduling appointments directly into coordinator calendars, and delivering multi-channel reminders. By automating these high-touch administrative tasks, the platform eliminates up to 90% of the manual burden currently placed on clinical research coordinators while maintaining a remarkable 95% prescreening accuracy rate. Key Features of the Autonomous AI Platform Autonomous Email Communication: AI agents send personalized introduction emails, deliver study information packets, and provide eligibility results instantly. The system intelligently monitors engagement and triggers follow-up actions based on patient behavior. Self-Service Appointment Scheduling: Real-time synchronization with Google Calendar, Outlook, and major CTMS platforms allows patients to book enrollment appointments 24/7 without back-and-forth communication. Multi-Channel Reminder Sequences: A sophisticated, automated cadence of phone calls, SMS, and emails ensures patients remain engaged, reducing no-show rates through intelligent, two-way confirmation. Patient-Directed Callback Scheduling: Unlike human coordinators who may struggle with "phone tag," the AI agent asks patients for their preferred callback time and executes that call with 100% reliability at the exact minute requested. Context-Aware Continuity: The platform’s "Relay AI" ensures that every interaction—whether via email or phone—resumes exactly where the last one left off, referencing specific patient details like medication lists or previous health history. How It Works: The Autonomous Workflow The TheraNovex platform transforms a process that typically takes 2-3 hours of manual coordinator time into a seamless, zero-intervention experience. When a patient clicks a recruitment ad, the AI agent immediately sends a welcome email and eligibility screener. If the patient qualifies, the AI initiates a phone call within five minutes to conduct a deep-dive prescreening. If a patient needs to gather more information, such as a medication list, the AI agent schedules a callback at the patient's convenience. Once fully qualified, the AI provides a personalized scheduling link, books the appointment into the site's calendar, and initiates a multi-touch reminder sequence (7 days, 3 days, 24 hours, and 2 hours before the visit). The coordinator simply meets a qualified, confirmed, and prepared patient on the day of the appointment. Unprecedented Efficiency Benefits Traditional recruitment workflows are plagued by delays, with manual responses often taking hours or days, leading to high patient drop-off rates. TheraNovex’s autonomous agents provide instant gratification and 24/7 availability. Statistics from early pilot programs indicate: 90% Reduction in coordinator administrative tasks. 95% Accuracy in clinical prescreening data compared to human counterparts. Zero Missed Callbacks, ensuring no potential participant is lost to follow-up. Real-time Calendar Optimization, grouping similar appointments to maximize site throughput. "The clinical research industry has reached a breaking point with coordinator burnout and recruitment delays. By moving from AI-assisted tools to fully autonomous agents, we are giving hours of time back to site staff, allowing them to focus on patient care rather than scheduling logistics. This isn't just an improvement; it's a total reimagining of how patients enter clinical trials." — CEO of TheraNovex Compliance and Security TheraNovex maintains a steadfast commitment to data integrity and patient privacy. The autonomous platform is fully HIPAA and GDPR compliant, utilizing enterprise-grade encryption for all communications. Jennifer Walsh, VP of Regulatory Affairs, notes that the system includes built-in escalations to human staff for complex medical questions, ensuring the highest standards of safety and regulatory adherence are met throughout the autonomous journey. About TheraNovex TheraNovex is a premier clinical trial recruitment company dedicated to accelerating the delivery of life-saving therapies through advanced technology. By combining deep clinical expertise with cutting-edge AI, TheraNovex helps pharmaceutical companies and research sites reach enrollment goals faster and more efficiently than traditional methods. Media Contact Sarah Thompson VP of Clinical Operations, TheraNovex Email: media@theranovex.com Website: www.theranovex.com

TheraNovex Launches AI-Powered Marketing Suite to Revolutionize Clinical Trial Recruitment

New AI-driven tools streamline recruitment ad copy, email outreach, and phone scripts to accelerate patient enrollment and optimize compliance.

San Francisco, CA — February 1, 2026 — TheraNovex, a global leader in clinical trial patient recruitment, today announced the launch of its AI-Powered Marketing Suite. This comprehensive digital ecosystem is designed to eliminate the creative bottlenecks that frequently delay clinical trial enrollment by automating the generation of high-converting, compliant, and platform-specific recruitment content. In an industry where 80% of clinical trials fail to meet enrollment timelines, the TheraNovex AI-Powered Marketing Suite offers a data-driven solution. By leveraging machine learning models trained on thousands of successful recruitment campaigns across diverse therapeutic areas, the suite provides research sites, CROs, and pharmaceutical sponsors with the tools necessary to reach the right patients at the right time. Key Features of the AI-Powered Marketing Suite AI Ad Copy Generator: Produces multiple variations of high-converting ad copy optimized for Facebook, Google, Instagram, and LinkedIn. The tool includes built-in emotional resonance analysis to ensure patient engagement remains high while maintaining professional standards. Generic Ad Copy Engine: A versatile tool for rapid-response marketing needs, offering a template library for common therapeutic areas and customizable brand voice settings. Email Outreach Generator: Automates personalized business development sequences for sponsors and CROs, featuring response rate tracking and seamless integration with drip campaign systems. Phone Script Generator: Provides effective, compliance-reviewed scripts for patient outreach, including specific modules for objection handling and warm transfer protocols for site coordinators. Dynamic Outreach Scripting: A new, adaptive tool that adjusts messaging based on real-time patient personas and recruitment milestones. How It Works: From Concept to Campaign in Minutes The TheraNovex AI-Powered Marketing Suite functions by synthesizing complex protocol requirements into accessible, patient-centric messaging. To begin, users input the specific therapeutic area and study parameters into the central dashboard. The AI then references its database of successful recruitment patterns to generate a variety of content assets. The workflow is designed for maximum efficiency. For example, the Ad Copy Generator creates dozens of A/B test variations simultaneously, allowing marketing teams to identify high-performing creative assets before significant budget is deployed. Simultaneously, the Phone Script Generator produces tailored call guides that align with the digital ad messaging, ensuring a consistent patient experience from the first click to the final screening call. This integrated approach ensures that messaging is not only creative but also strategically aligned across all touchpoints. Significant Benefits for Clinical Research Teams The implementation of these AI tools results in measurable improvements across the recruitment lifecycle. Early data indicates that the TheraNovex suite can save marketing teams up to 40 hours of creative development time per study. By utilizing copy patterns proven to convert, sponsors have observed a 25% increase in lead generation efficiency compared to traditional manual drafting methods. Furthermore, the democratization of these tools through a robust free tier allows smaller research sites and emerging biotech firms to access professional-grade marketing resources that were previously reserved for large-scale operations. This accessibility ensures that critical medical research is not delayed by a lack of marketing infrastructure. Compliance and Security at the Forefront Understanding the rigorous regulatory environment of clinical trials, TheraNovex has integrated automated compliance checking into every tool within the suite. The AI is programmed to recognize and flag language that may be perceived as coercive or misleading, ensuring that all generated copy adheres to Institutional Review Board (IRB) and international regulatory guidelines. This proactive approach significantly reduces the risk of regulatory delays and ensures that patient safety and ethics remain the priority. Data security is equally paramount. The suite operates within a secure, encrypted environment, ensuring that all proprietary study information and campaign data are protected according to industry-leading standards. About TheraNovex TheraNovex is a premier clinical trial patient recruitment company dedicated to bridging the gap between innovative medical research and the patients who need it most. By combining deep industry expertise with cutting-edge technology, TheraNovex provides comprehensive recruitment solutions that accelerate the delivery of life-saving therapies to market. The company specializes in data-driven digital marketing, patient advocacy engagement, and site-level support services. Media Contact: TheraNovex Team Email: media@theranovex.com Website: www.theranovex.com

TheraNovex Launches Integrated Rideshare Technology to Eliminate Clinical Trial Participation Barriers

TheraNovex partners with Uber Health to provide seamless patient transportation, reducing clinical trial no-show rates by 35% through integrated scheduling and real-time tracking.

San Francisco, CA — February 1, 2026 — TheraNovex, a global leader in clinical trial patient recruitment and retention solutions, today announced the launch of its groundbreaking Integrated Rideshare Technology. This innovative solution, powered by a strategic integration with Uber Health, is designed to eliminate one of the most significant hurdles in clinical research: patient transportation. By embedding seamless ride-hailing capabilities directly into the TheraNovex recruitment ecosystem, the company is addressing the logistical challenges that frequently lead to participant attrition and missed study visits. Transportation remains a primary barrier to clinical trial diversity and retention, particularly for patients in underserved urban areas or those with mobility limitations. TheraNovex’s new platform addresses these inequities by providing a centralized, sponsor-funded transportation portal that requires no smartphone or app usage from the patient side, ensuring that participation is accessible to all demographics regardless of technological literacy or socio-economic status. Key Features of the TheraNovex Rideshare Solution Seamless Ride Scheduling: Study coordinators can book on-demand or scheduled rides for participants directly through the TheraNovex dashboard, syncing perfectly with study visit windows. Real-Time Coordinator Tracking: Site staff gain a live bird’s-eye view of participant transit status, allowing clinics to optimize their daily workflows and prepare for patient arrival. Automated Appointment Reminders: The system sends multi-channel notifications (SMS and Voice) to patients, offering a pre-arranged ride as part of the visit reminder. Centralized Cost Management: Integrated financial tools allow sponsors to track transportation spend in real-time, with automated reimbursement workflows that eliminate manual paperwork. Multilingual Support: The interface and patient communications are available in over 15 languages to support global clinical programs. How It Works: A Frictionless Experience The TheraNovex Rideshare Technology is designed to function as a bridge between the clinical site and the patient’s home. When a patient is enrolled in a trial via the TheraNovex platform, their transportation needs are assessed during the onboarding phase. Once a study visit is scheduled, the platform automatically triggers a ride offer via the patient’s preferred communication channel. Upon confirmation, the system coordinates with Uber Health to dispatch a driver at the appropriate time. Site coordinators receive a notification when the patient is en route, when they have arrived at the clinic, and when they are ready for their return trip. This end-to-end visibility ensures that the "last mile" of clinical trial participation is no longer a dark spot in the study timeline. Furthermore, the platform handles all backend billing, ensuring that the patient never has to pay out-of-pocket or navigate complex reimbursement forms. Quantifiable Benefits for Sponsors and Sites Early pilot programs utilizing the TheraNovex Rideshare Technology have demonstrated transformative results for clinical trial operations. Data collected over a twelve-month period across 40 global sites revealed a 35% reduction in patient no-show rates. By stabilizing the patient schedule, sites reported a 20% increase in overall operational efficiency, as staff spent less time rescheduling missed appointments and more time on high-value clinical tasks. Beyond retention, the technology significantly bolsters recruitment efforts. Potential participants are more likely to enroll in a study when they are guaranteed reliable, safe, and free transportation. This has proven particularly effective in Phase II and Phase III trials involving elderly populations or patients with chronic conditions that make driving or navigating public transit difficult. "The launch of our Integrated Rideshare Technology represents a pivotal shift in how we approach patient centricity. We aren't just finding patients for trials; we are ensuring they have the means to stay in them. By removing the stress of transportation, we are allowing patients to focus entirely on their health and their contribution to medical science. This is about equity, efficiency, and ultimately, accelerating the delivery of life-saving therapies to market." — Dr. Emily Carter, CEO of TheraNovex Uncompromising Compliance and Security In the highly regulated world of clinical research, data integrity and patient privacy are paramount. TheraNovex has developed this integration with a "compliance-first" architecture. The platform is fully HIPAA-compliant and adheres to GDPR standards for international studies. By utilizing the Uber Health API, TheraNovex ensures that sensitive patient health information (PHI) is never shared with drivers. Drivers only receive the necessary pickup and drop-off information, while all clinical data remains encrypted within the TheraNovex secure environment. Jennifer Walsh, VP of Regulatory Affairs at TheraNovex, emphasized the rigor of the system: "Our integration underwent exhaustive auditing to ensure it meets the highest standards of data security. We have successfully bridged the gap between consumer-grade convenience and clinical-grade security, ensuring that sponsors can provide this service with total confidence in their regulatory standing." About TheraNovex TheraNovex is a premier clinical trial patient recruitment and retention company headquartered in San Francisco. Combining cutting-edge data analytics with a human-centric approach, TheraNovex helps pharmaceutical and biotech companies reach their enrollment goals faster and more reliably. With a suite of proprietary tools ranging from AI-driven patient identification to integrated logistics management, TheraNovex is dedicated to modernizing the clinical trial experience for sponsors, sites, and patients alike. Media Contact Information Contact: Media Relations Team, TheraNovex Email: press@theranovex.com Phone: (555) 123-4567 Website: www.theranovex.com

TheraNovex AI Agent Generates Complete Clinical Trial Marketing Campaigns in 10 Minutes

TheraNovex launches revolutionary AI Creative Studio that automates the generation of IRB-compliant flyers, ad copy, graphics, and radio commercials from a single click.

San Francisco, CA, February 1, 2026 — TheraNovex, a leader in clinical trial patient recruitment technology, today announced the launch of its Study Ad Materials AI Agent. This first-of-its-kind AI Creative Studio eliminates the traditional weeks-long process of creating recruitment marketing materials, allowing research sites and sponsors to generate complete, IRB-compliant multi-channel campaigns in just 10 minutes. By simply inputting a study’s inclusion and exclusion criteria, the TheraNovex AI Agent produces a comprehensive marketing toolkit that previously required a full team of graphic designers, copywriters, compliance reviewers, and audio production studios. The platform marks a significant shift in clinical trial operations, reducing marketing production time by 90% and saving sponsors between $5,000 and $15,000 in creative costs per study. Key Features of the AI Creative Studio IRB-Compliant Flyers: Automatically generates professional layouts with study-appropriate imagery, required regulatory disclaimers, and clear calls-to-action in multiple print and digital formats. Platform-Specific Ad Copy: Creates optimized headlines and descriptions for Google Ads, Facebook, Instagram, Twitter/X, and LinkedIn, ensuring compliance with each platform's specific healthcare advertising policies. Custom Graphics & Social Assets: Produces high-resolution visual assets tailored to different social media dimensions, including Instagram Stories and Google Display ads. Patient Screening Scripts: Develops conversational scripts for coordinators that convert complex clinical criteria into easy-to-understand questions with built-in skip logic. Broadcast-Ready Radio Commercials: Generates professional audio spots (15, 30, and 60 seconds) featuring human-quality AI voice talent and royalty-free background music matched to the study's therapeutic area. How It Works: From Criteria to Campaign in 10 Minutes The TheraNovex Study Ad Materials AI Agent replaces a traditional 2-to-4-week production cycle with a streamlined three-step automated workflow: Step 1: Input Study Criteria (2 minutes) – The user enters the study title, therapeutic area, and copies/pastes the inclusion and exclusion criteria directly from the protocol. Users can also select target demographics such as age, gender, and location. Step 2: Automated AI Generation (5 minutes) – The AI analyzes the clinical requirements to generate messaging that is both compelling to patients and compliant with regulatory standards. It simultaneously designs graphics, writes platform-specific copy, and produces fully mixed audio files. Step 3: Review and Deploy (3 minutes) – The user previews the generated materials in a comprehensive toolkit. Minor adjustments can be made instantly before downloading the assets for immediate deployment across recruitment channels. Significant Benefits for Clinical Research The transition from traditional manual creation to AI-driven generation offers transformative advantages for the industry: Speed to Enrollment: What once took 60-100 labor hours is now condensed into 10 minutes, allowing for same-day campaign launches and rapid enrollment acceleration. Cost Efficiency: Eliminates the need for external creative vendors, music licensing fees, and expensive voice talent sessions. All tools are included within the TheraNovex platform. Design Intelligence: The AI selects imagery and color schemes based on proven performance data for specific therapeutic areas, ensuring high engagement with target patient populations. Scalability: Pharmaceutical sponsors can now launch recruitment across hundreds of sites with consistent, high-quality messaging, while small research sites can compete with larger networks by utilizing professional-grade marketing materials. Compliance and Security TheraNovex has prioritized regulatory integrity within the AI Agent’s core logic. The system is programmed to avoid overpromising or coercive language, and it automatically includes required disclosures, such as principal investigator credentials and HIPAA privacy statements. By standardizing regulatory language, the platform helps reduce IRB review times and provides a clear audit trail for all generated materials, ensuring that every asset meets the rigorous standards of clinical research advertising. About TheraNovex TheraNovex is a leading clinical trial patient recruitment company dedicated to accelerating medical innovation through technology. By combining advanced AI with deep clinical expertise, TheraNovex provides research sites, CROs, and sponsors with the tools necessary to reach the right patients at the right time, reducing the time and cost of bringing new therapies to market. Media Contact: TheraNovex Team Email: media@theranovex.com Website: www.theranovex.com

TheraNovex Agentic AI Manages Clinical Trial Recruitment Campaigns Across 100+ Sites

TheraNovex launches a revolutionary central campaign platform using autonomous AI agents to manage budgets and optimize recruitment efficiency across multi-site clinical trials.

San Francisco, CA, February 1, 2026 — TheraNovex, a leader in clinical trial patient recruitment technology, today announced the launch of its revolutionary central campaign management platform. Powered by Agentic AI, the platform enables pharmaceutical sponsors to deploy recruitment campaigns across more than 100 research sites simultaneously. By utilizing autonomous AI agents to manage budgets and optimize performance in real-time, the system consistently outperforms human ad managers by 40% in cost-per-enrollment efficiency. As clinical trials grow in complexity and geographic scale, traditional site-by-site recruitment methods have become a significant bottleneck. TheraNovex’s new platform addresses these challenges by offering the industry’s first true "set it and forget it" recruitment solution. The Agentic AI architecture allows for sponsor-funded central campaigns to be deployed across an entire site network from a single dashboard, ensuring consistent messaging while maintaining the flexibility for site-specific customization. Key Features of the Agentic AI Platform Autonomous Budget Allocation: AI agents make thousands of micro-decisions daily, shifting spend to the highest-performing sites and channels without human intervention. Massive Multi-Site Deployment: Launch standardized recruitment campaigns across 100+ sites with a single click, eliminating months of site-by-site setup. Predictive Enrollment Analytics: Advanced forecasting agents adjust budgets proactively based on site capacity, local demographics, and real-time conversion data. Cross-Site Intelligence: The system identifies successful strategies at top-performing sites and automatically applies those learnings across the entire network. Multi-Channel Optimization: Simultaneous management of bid strategies across Facebook, Google, Instagram, and programmatic display networks. How It Works The platform utilizes a sophisticated Agentic AI architecture where multiple specialized agents collaborate to achieve enrollment targets. A Budget Allocation Agent manages the distribution of spend across the network, while a Performance Optimization Agent continuously A/B tests over 1,000 ad variations to identify winning creative combinations. Simultaneously, a Capacity Management Agent monitors each site’s screening bandwidth in real-time. If a site approaches its maximum processing capacity, the AI automatically reduces ad spend for that specific location to prevent lead overflow and wasted resources, reallocating those funds to sites that are falling behind their enrollment targets. Operational Benefits and Efficiency The shift from human-managed to AI-managed recruitment campaigns delivers significant measurable improvements to clinical trial timelines and budgets. By operating 24/7 and responding to performance changes within minutes rather than weeks, the TheraNovex platform provides: 45% reduction in cost-per-enrollment compared to human-managed campaigns. 30% reduction in total recruitment spend through the elimination of wasted leads and inefficient ad placements. 50% faster enrollment timelines due to optimized resource allocation and rapid scaling capabilities. Unified Reporting: Sponsors gain a single source of truth with real-time dashboards showing enrollment by site, channel, and campaign. Site-Level Intelligence and Quality Assurance Beyond budget management, the platform enhances the quality of the recruitment funnel. The AI integrates seamlessly with TheraNovex’s prescreening agents to ensure that only highly qualified patients are delivered to site coordinators. This coordination prevents site staff from being overwhelmed by low-quality leads and ensures that recruitment efforts are perfectly aligned with site availability. This centralized control allows pharmaceutical sponsors and Contract Research Organizations (CROs) to maintain high standards of lead quality and regulatory compliance across diverse geographic regions. Compliance and Security TheraNovex maintains a rigorous focus on data integrity and regulatory compliance. The platform includes automated compliance checking for IRB and regulatory requirements, ensuring all ad creative and messaging remain within approved parameters. The system is designed to meet the highest standards of data security, providing sponsors with peace of mind while managing sensitive recruitment data across large-scale, multi-site trials. About TheraNovex TheraNovex is a leading clinical trial patient recruitment company dedicated to accelerating the delivery of life-saving therapies. By combining deep clinical expertise with cutting-edge Agentic AI technology, TheraNovex provides pharmaceutical sponsors and CROs with the tools necessary to solve the most complex enrollment challenges. The company’s platform streamlines the recruitment process, reduces costs, and improves the experience for both research sites and patients. Media Contact: TheraNovex Team Email: media@theranovex.com Website: www.theranovex.com

TheraNovex Launches AI-Driven Patient Retention Suite to Combat Clinical Trial Attrition

TheraNovex introduces an advanced automated appointment reminder system designed to reduce patient dropout rates by 40% and streamline clinical trial operations.

San Francisco, CA — February 1, 2026 — TheraNovex, a global leader in clinical trial patient recruitment and retention solutions, today announced the launch of its next-generation Appointment Reminder and Engagement Suite. This sophisticated, AI-driven platform is specifically engineered to address the critical challenge of patient attrition in clinical research, ensuring that life-saving therapies reach the market faster through improved protocol adherence and participant engagement. Revolutionizing Clinical Trial Retention Patient dropout remains one of the most significant hurdles in modern drug development, with industry data suggesting that nearly 30% of participants discontinue trials before completion. TheraNovex’s new suite addresses this by integrating seamless, multi-channel communication tools that keep participants informed, motivated, and on schedule. By automating the follow-up process, the platform alleviates the administrative burden on site staff while providing patients with the personalized support they need to navigate complex trial schedules. Key Features of the TheraNovex Engagement Suite Multi-Channel Synchronization: Automated reminders delivered via SMS, encrypted email, and push notifications based on individual patient preferences. Intelligent Rescheduling Logic: An AI-driven interface that allows patients to request appointment changes instantly, which are then synchronized with site calendars in real-time. Travel and Logistics Integration: Automated prompts that include GPS directions to the clinical site, integrated ride-share hailing, and weather alerts for the day of the visit. Multilingual Support: Capability to deliver reminders in over 40 languages, ensuring inclusivity and clarity for diverse global patient populations. Gamified Adherence Tracking: A patient-facing dashboard that rewards consistent attendance and protocol compliance with milestone badges and educational content. How It Works: A Seamless Connection Between Site and Patient The TheraNovex platform functions as a sophisticated bridge between the Clinical Trial Management System (CTMS) and the participant’s daily life. Once a patient is randomized into a study, the system automatically maps out their entire visit schedule based on the study protocol. Using predictive analytics, the software identifies potential "friction points"—such as long intervals between visits or complex fasting requirements—and increases engagement during those periods. Forty-eight hours before a scheduled visit, the patient receives a personalized notification detailing the time, location, and any necessary preparations (such as medication fasting). If a patient fails to acknowledge the reminder, the system triggers a secondary alert to the site coordinator, allowing for proactive human intervention before a missed visit occurs. This proactive approach ensures that the "lost to follow-up" metric is minimized across the duration of the study. Quantifiable Benefits for Sponsors and Sites The implementation of the TheraNovex Appointment Reminder system offers measurable improvements across several key performance indicators: 40% Reduction in Attrition: Early pilot programs have demonstrated a significant decrease in patient dropout rates, particularly in Phase II and III longitudinal studies. 25% Increase in Site Efficiency: Automated reminders reduce the time site coordinators spend on manual phone calls and administrative scheduling by an average of 10 hours per week. Enhanced Data Integrity: Higher attendance rates lead to more complete data sets, reducing the need for statistical "imputation" and strengthening the validity of the trial results. Improved Patient Satisfaction: Post-trial surveys indicate that 92% of participants felt more supported and valued when receiving consistent, professional communication through the TheraNovex platform. "The greatest tragedy in clinical research is when a promising therapy is delayed because we couldn't keep participants engaged. Our new Appointment Reminder Suite isn't just about sending texts; it's about building a digital infrastructure of empathy and reliability. By removing the logistical stressors of trial participation, we are empowering patients to stay the course and help bring new medicines to the world." — CEO of TheraNovex Uncompromising Compliance and Security In the highly regulated environment of clinical research, data security is paramount. TheraNovex has developed this platform with a "Privacy by Design" philosophy. The suite is fully compliant with HIPAA, GDPR, and 21 CFR Part 11 regulations. All patient data is encrypted both in transit and at rest, and the system ensures that Personally Identifiable Information (PII) is strictly siloed from clinical trial data, maintaining the integrity of blinded studies. Jennifer Walsh, VP of Regulatory Affairs, noted: "We have worked closely with institutional review boards (IRBs) to ensure that our communication templates meet the highest ethical standards, ensuring that reminders are informative and supportive without being coercive." About TheraNovex TheraNovex is a leading clinical trial patient recruitment and retention firm headquartered in San Francisco. Since its inception, TheraNovex has specialized in leveraging high-tech data analytics and high-touch patient advocacy to accelerate the clinical trial process. Serving the world’s top pharmaceutical, biotech, and medical device companies, TheraNovex is committed to making clinical trials more accessible, diverse, and efficient through innovative digital solutions. Media Contact Information Contact: The Thearnovex Team Email: media@theranovex.com Website: www.theranovex.com

TheraNovex Introduces Comprehensive IRB Checklist Tool and Interactive GCP Quiz Platform Revolutionizes Research Training

Dual platform launch streamlines IRB submissions and transforms GCP training with 90% improved knowledge retention

TheraNovex today announced the simultaneous launch of two groundbreaking platforms: the Comprehensive IRB Checklist Tool and the Interactive GCP Quiz Platform.The IRB Checklist Tool revolutionizes Institutional Review Board submission preparation with comprehensive digital checklists and automated document verification, reducing submission errors by 85% and accelerating approval timelines through systematic preparation guidance, real-time compliance checking, and integrated submission tracking.Meanwhile, the Interactive GCP Quiz Platform transforms Good Clinical Practice training through gamified learning experiences, featuring adaptive questioning, real-time feedback, and progress tracking that results in 90% improved knowledge retention compared to traditional training methods.Both platforms include custom creation capabilities and team management features to enhance research efficiency across organizations.

TheraNovex Launches Uber-Powered Ride Share Technology for Clinical Trial Participants

Revolutionary transportation solution eliminates travel barriers and increases trial participation by 40%

TheraNovex today announced the launch of its groundbreaking ride share technology platform specifically designed for clinical trial participants.This innovative solution partners with leading ride-sharing services to provide seamless, sponsored transportation to and from study visits, eliminating one of the most significant barriers to clinical trial participation.The platform features automated scheduling that syncs with study visit calendars, real-time tracking for research coordinators, comprehensive cost management with sponsor billing integration, and accessibility options for participants with special transportation needs.Early pilot programs have shown a 40% increase in participant enrollment and a 35% reduction in missed appointments.

TheraNovex Announces Launch of StudyLoop.io Platform

Revolutionary AI-powered platform reduces clinical trial recruitment timelines by up to 65%

Birmingham, AL - May 15, 2025 - TheraNovex, a leading clinical research technology company, today announced the official launch of StudyLoop.io, a revolutionary AI-powered platform designed to transform clinical trial recruitment and patient engagement across the healthcare industry.The StudyLoop.io platform addresses one of the most significant challenges facing clinical research today: inefficient patient recruitment and retention.Game-Changing Technology for Clinical ResearchStudyLoop.io leverages advanced artificial intelligence and machine learning algorithms to streamline the entire patient recruitment process. The platform's precision matching technology analyzes thousands of data points to identify and connect the most suitable participants with appropriate clinical trials, reducing recruitment timelines by up to 65%.

TheraNovex Unveils AI-Powered Eligibility Screener Tool

Automated pre-screening reduces participant qualification time by 80%

TheraNovex today announced the launch of its intelligent Eligibility Screener, a breakthrough tool that automates participant pre-qualification for clinical trials.This AI-powered solution analyzes participant responses in real-time, instantly determining study eligibility and reducing manual screening time by up to 80%.The tool integrates seamlessly with existing study workflows and provides detailed analytics on screening success rates.

Revolutionary Budget Planner Tool Launched for Clinical Trials

Comprehensive financial planning tool helps researchers optimize trial budgets

TheraNovex introduces its comprehensive Budget Planner tool, designed to streamline financial planning for clinical trials.The platform provides detailed cost breakdowns, real-time budget tracking, and predictive analytics to help research teams optimize their trial investments.With built-in templates for various study types and automatic cost calculations, the Budget Planner reduces planning time by 60%.

TheraNovex Launches Advanced Consent Builder Platform

Streamlined informed consent creation reduces document preparation time by 70%

The new Consent Builder from TheraNovex revolutionizes informed consent document creation for clinical trials.This intelligent platform automatically generates compliant consent forms based on study parameters, ensuring regulatory compliance while reducing preparation time by 70%.The tool includes version control, electronic signature capabilities, and multi-language support.

Innovative Training Tracker Tool Enhances Research Team Management

Comprehensive training management system ensures GCP compliance across research teams

TheraNovex announces the launch of its Training Tracker tool, a comprehensive solution for managing research team certifications and training requirements.The platform automatically tracks GCP training, protocol-specific education, and certification renewals, ensuring 100% compliance while reducing administrative burden by 65%.Features include automated reminders, progress tracking, and detailed reporting.

TheraNovex Introduces Comprehensive IRB Checklist Tool

Digital checklist system accelerates IRB submission preparation and approval processes

The new IRB Checklist tool from TheraNovex streamlines Institutional Review Board submission preparation with comprehensive digital checklists and automated document verification.This tool reduces submission errors by 85% and accelerates approval timelines through systematic preparation guidance, real-time compliance checking, and integrated submission tracking.

Advanced Data Anonymizer Tool Launched for Clinical Research

State-of-the-art anonymization technology ensures participant privacy and regulatory compliance

TheraNovex unveils its sophisticated Data Anonymizer tool, designed to protect participant privacy while maintaining data utility for clinical research.The platform uses advanced algorithms to anonymize sensitive data while preserving statistical relationships essential for analysis.This tool ensures HIPAA compliance and supports international privacy regulations.

Interactive GCP Quiz Platform Revolutionizes Research Training

Gamified learning platform improves GCP knowledge retention by 90%

TheraNovex launches its innovative GCP Quiz platform, transforming Good Clinical Practice training through interactive, gamified learning experiences.The platform features adaptive questioning, real-time feedback, and progress tracking, resulting in 90% improved knowledge retention compared to traditional training methods.Custom quiz creation and team management features enhance training efficiency.

TheraNovex Launches Intelligent Funding Finder for Clinical Trials

AI-powered platform matches researchers with optimal funding opportunities

The new Funding Finder tool from TheraNovex uses artificial intelligence to match clinical trials with appropriate funding sources.This comprehensive platform analyzes study parameters, budget requirements, and eligibility criteria to identify optimal funding opportunities from government grants, private foundations, and industry sponsors.The tool has already helped researchers secure over $50 million in funding.

TheraNovex today announced the exclusive beta launch of StudyLoop.io, our innovative platform designed to revolutionize patient recruitment and retention in clinical trials. This invitation-only beta program allows selected research sites to experience the full power of our AI-driven solution at no cost.

Key features of StudyLoop.io Beta include:

• AI-powered patient matching that reduces recruitment timelines by up to 65%
• Comprehensive patient engagement tools to improve retention rates
• Real-time analytics dashboard for monitoring recruitment progress
• Automated pre-screening to identify ideal candidates
• Secure communication channels between research staff and patients

"We've been developing StudyLoop.io with direct input from research sites to ensure it addresses their most pressing challenges," explained Dr. Marcus Wei, VP of Clinical Operations at TheraNovex. "This beta launch represents our commitment to providing solutions that make a real difference in clinical trial efficiency and outcomes."

Research sites interested in joining the beta program are encouraged to join our waitlist. Selected sites will receive full access to the platform, comprehensive training, and dedicated support throughout the beta period.